Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
fludeoxyglucose f-18 (1 trial)
Carcinoma (Phase 3)
Carcinoma, Squamous Cell (Phase 3)
Head and Neck Neoplasms (Phase 3)
Trials (1 total)
Trial APIs (1 total)